Celcuity

Celcuity Assets per Share

The Total Assets per Share of Celcuity (CELC) as of Oct 5, 2026 is 11.83 USD. In the previous year, Total Assets per Share was 6.21 USD — a change of 90.34% (higher).

Assets per Share

11.83USD

YoY

90.34%

Last updated:

Total Assets per Share of Celcuity is 2026 11.83 USD. Total Assets per Share of Celcuity was 2025 6.21 USD. It decreases by 90.34% higher compared to the previous year.

The Celcuity Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
0.66 USD
Jan 1, 2019
0.51 USD
Jan 1, 2020
0.33 USD
Jan 1, 2021
2.18 USD
Jan 1, 2022
4.45 USD
Jan 1, 2023
4.85 USD
Jan 1, 2024
6.21 USD
Jan 1, 2025
11.83 USD
The Celcuity Assets per Share history
YEARAssets per ShareYoY
11.83USD+90.34%
6.21USD+28.19%
4.85USD+8.83%
4.45USD+104.52%
2.18USD+563.02%
0.33USD-36.11%
0.51USD-22.09%
0.66USD-18.57%
0.81USD+427.81%
0.15USD+14.28%
0.13USD—
Access this data via the Eulerpool API

Celcuity Stock analysis

What does Celcuity do? Celcuity Inc is a biotechnology company founded by Brian Sullivan in 2012. The company is headquartered in Minneapolis, USA. The business model of Celcuity is based on researching and developing new diagnostic and treatment methods for various types of cancer. The company utilizes a proprietary technology platform called CELx, which enables the analysis of cancer cell signaling pathways and the development of individualized treatment strategies. Celcuity specializes in the development of diagnostics and personalized therapies based on individual cancer cell signaling pathways. The company operates in two divisions: 1. Diagnostics division: Celcuity's diagnostics division focuses on identifying new cancer markers and biomarkers for early detection of cancer and the development of individualized treatment strategies. 2. Therapy division: Celcuity's therapy division specializes in the development of personalized therapies based on individual cancer cell signaling pathways. Celcuity currently offers two products based on the CELx technology platform: 1. CELx HUB: CELx HUB is a cloud-based software that allows doctors and researchers to analyze cancer samples and develop individualized treatment strategies. 2. CELx TIL: CELx TIL is a diagnostic tool that measures the presence of tumor cells in the immune system of cancer patients. In summary, Celcuity Inc is a leader in the field of personalized cancer therapy based on individual cancer cell signaling pathways. The company has found a niche in this growing market and has a unique technology platform that allows it to serve its customers effectively. With its products and services, Celcuity is helping to revolutionize cancer treatment and improve the quality of life for cancer patients worldwide. Celcuity is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celcuity stock

Total Assets per Share of Celcuity is 11.83 USD in 2026.

Total Assets per Share of Celcuity changed from 6.21 USD to 11.83 USD, representing a 90.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Celcuity since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

Other — Celcuity

All Key Metrics — Celcuity